Twin Peaks Wealth Advisors, LLC Ligand Pharmaceuticals Inc Transaction History
Twin Peaks Wealth Advisors, LLC
- $309 Billion
- Q2 2025
A detailed history of Twin Peaks Wealth Advisors, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Twin Peaks Wealth Advisors, LLC holds 45 shares of LGND stock, worth $8,217. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45Holding current value
$8,217% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LGND
# of Institutions
290Shares Held
19.5MCall Options Held
9KPut Options Held
0-
Black Rock Inc. New York, NY2.87MShares$524 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$382 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.06MShares$194 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3927KShares$169 Million0.13% of portfolio
-
State Street Corp Boston, MA750KShares$137 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $3.08B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...